HELIUS MEDICAL TECHNOLOGIES, INC. Quarterly Debt-to-equity in % from Q4 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Helius Medical Technologies, Inc. quarterly Debt-to-equity history and growth rate from Q4 2015 to Q3 2024.
  • Helius Medical Technologies, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 92.6 %, a 30% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 92.6 -39.6 -30% Sep 30, 2024
Q2 2024 127 +36.4 +40% Jun 30, 2024
Q1 2024 177 +98.9 +127% Mar 31, 2024
Q4 2023 156 +96.7 +162% Dec 31, 2023
Q3 2023 132 +95.2 +257% Sep 30, 2023
Q2 2023 91 +54.4 +149% Jun 30, 2023
Q1 2023 78.2 +45.1 +136% Mar 31, 2023
Q4 2022 59.8 +30.2 +102% Dec 31, 2022
Q3 2022 37 +0.58 +1.59% Sep 30, 2022
Q2 2022 36.6 -2.26 -5.82% Jun 30, 2022
Q1 2022 33.1 -8.6 -20.6% Mar 31, 2022
Q4 2021 29.6 -29.7 -50.1% Dec 31, 2021
Q3 2021 36.5 -26.1 -41.7% Sep 30, 2021
Q2 2021 38.9 -15 -27.8% Jun 30, 2021
Q1 2021 41.7 -11.1 -21% Mar 31, 2021
Q4 2020 59.3 -2.75 -4.44% Dec 31, 2020
Q3 2020 62.5 -24.7 -28.3% Sep 30, 2020
Q2 2020 53.8 -117 -68.5% Jun 30, 2020
Q1 2020 52.8 -1.35K -96.2% Mar 31, 2020
Q4 2019 62 +881 Dec 31, 2019
Q3 2019 87.2 +351 Sep 30, 2019
Q2 2019 171 +375 Jun 30, 2019
Q1 2019 1.41K +1.63K Mar 31, 2019
Q4 2018 -819 -566 -223% Dec 31, 2018
Q3 2018 -263 +10.3 +3.77% Sep 30, 2018
Q2 2018 -204 +1.65K +89% Jun 30, 2018
Q1 2018 -228 -1.15K -125% Mar 31, 2018
Q4 2017 -253 -796 -147% Dec 31, 2017
Q3 2017 -274 -675 -168% Sep 30, 2017
Q2 2017 -1.85K -2.99K -263% Jun 30, 2017
Q1 2017 919 +1.22K Mar 31, 2017
Q4 2016 543 +763 Dec 31, 2016
Q3 2016 401 Sep 30, 2016
Q2 2016 1.14K Jun 30, 2016
Q1 2016 -304 Mar 31, 2016
Q4 2015 -220 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.